There remains no evidence to support the use of ivermectin for treating or preventing COVID-19 infection, state the authors of an updated Cochrane Review, which now contains 11 trials across 3409 people. The authors note that evidence is limited, and evaluation of ivermectin is continuing in ongoing studies. 

In this instalment of the CIDG 'Meet the Editor' series, we talk with Dr Joseph Pryce from the UK.

How accurate are symptoms and medical examination to diagnose COVID‐19?Key messages‐ The results suggest that a single symptom included in this review cannot accurately diagnose COVID‐19.

Why is improving the diagnosis of tuberculosis drug resistance important?Tuberculosis tests, like Xpert MTB/RIF, Xpert MTB/RIF Ultra, and Truenat, only diagnose rifampicin resistance, but do not provide information about resistance to other drugs used to treat tuberculosis. This information is needed to allow for effective treatment to be started quickly.

How accurate is chest imaging for diagnosing COVID‐19?Why is this question important?People with suspected COVID‐19 need to know quickly whether they are infected, so they can receive appropriate treatment, self‐isolate, and inform close contacts.

During April 2022, the CIDG published one new protocol and one new review in Issue 4, 2022 of the Cochrane Database of Systematic Reviews.

An exciting opportunity has arisen in LSTM's  Clinical Sciences team for an experienced Research Associate to join us. The Role:

Why is improving screening for tuberculosis of the lungs important?

Cochrane reviews on tests for tuberculosis disease and tuberculosis drug resistance